Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs

被引:27
作者
Bruheim, S
Krobert, KA
Andressen, KW
Levy, FO
机构
[1] Univ Oslo, Rikshosp, Univ Hosp, Dept Pharmacol, N-0027 Oslo, Norway
[2] Univ Oslo, Rikshosp, Univ Hosp, MSD Cardiovasc Res Ctr,Inst Surg Res, N-0027 Oslo, Norway
关键词
adenylyl cyclase; constitutive activity; coupling; efficacy; 5-HT4; 5-HT7; potency; preassociation; receptor; serotonin;
D O I
10.1080/10606820308245
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compared adenylyl cyclase (AC) activation by the G protein-coupled human serotonin (5-HT) receptors 5-HT4(b) and 5-HT7(a) using an ecdysone-inducible expression system, which allowed for reproducible expression of increasing receptor densities in clonal HEK293 (EcR293) cell lines. Low constitutive expression of receptors (2-70 fmol/mg protein) was observed and could be titrated up to 50-200-fold (similar to400-7000 fmol/mg protein) by the ecdysone analogue ponasterone A. Although 5-HT-stimulated AC activity increased with receptor density, interclonal variation precluded comparisons of coupling efficiency. Interestingly, the potency of 5-HT to stimulate AC increased with increasing receptor density only in clones expressing 5-HT4(b) receptors. The potency for 5-HT did not change in clones expressing 5-HT7(a) receptors, even though 5-HT-stimulated AC activity approached asymptotic levels. This indicates that potency of 5-HT for stimulation of AC through the 5-HT7(a) receptor is independent of receptor-G(s) stoichiometry and is consistent with a model where the 5-HT7(a) receptors are tightly associated with G protein, independent of agonist binding. This supports the existence of a complex between inactive receptor and G protein, as predicted by the cubic ternary complex model. In such a system, spare receptors do not lead to increased potency of an agonist with increased receptor density.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 38 条
  • [1] [H-3]5-Hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor
    Adham, N
    Gerald, C
    Schechter, L
    Vaysse, P
    Weinshank, R
    Branchek, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) : 231 - 235
  • [2] Adham N, 1998, J PHARMACOL EXP THER, V287, P508
  • [3] Allosteric modulation of the human 5-HT7A receptor by lipidic amphipathic compounds
    Alberts, GL
    Chio, CL
    Im, WB
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (06) : 1349 - 1355
  • [4] 5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle
    Bach, T
    Syversveen, T
    Kvingedal, AM
    Krobert, KA
    Brattelid, T
    Kaumann, AJ
    Levy, FO
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (02) : 146 - 160
  • [5] Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor
    Baker, LP
    Nielsen, MD
    Impey, S
    Metcalf, MA
    Poser, SW
    Chan, G
    Obrietan, K
    Hamblin, MW
    Storm, DR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) : 17469 - 17476
  • [6] OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM
    BLACK, JW
    LEFF, P
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219): : 141 - 162
  • [7] BOCKAERT J, 1976, J BIOL CHEM, V251, P2653
  • [8] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
    Bouaboula, M
    Perrachon, S
    Milligan, L
    Canat, X
    RinaldiCarmona, M
    Portier, M
    Barth, F
    Calandra, B
    Pecceu, F
    Lupker, J
    Maffrand, JP
    LeFur, G
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
  • [9] Chen G, 2000, MOL PHARMACOL, V57, P125
  • [10] Constantino S, 2001, EUR CYTOKINE NETW, V12, P365